Global Pharmaceutical Grade Injectable Activated Carbon market demonstrated robust expansion in 2023, reaching a valuation of USD 89 million. Industry projections indicate sustained momentum with an anticipated CAGR of 7.4%, propelling the market to USD 169.21 million by 2032. This growth trajectory stems from escalating demand for advanced detoxification therapies and stringent pharmaceutical...